Rights and Warrants Practice Questions for the SIE

Answer: the debentures can be offered with a lower coupon than the market would otherwise require

Warrants are attached to bond or preferred offerings as a sweetener: the long-term option to buy the issuer's stock makes the package more attractive, so investors accept a lower coupon on the debt — reducing the issuer's borrowing cost. Because the warrant's exercise price is set above the stock's market price at issuance, nobody exercises at the offering; any exercise proceeds arrive only years later if the stock appreciates, so 'immediate additional capital' reverses the timing. Protecting existing shareholders from dilution describes preemptive rights — the short-term, below-market subscription privilege — which is the classic rights-versus-warrants mix-up. And warrants themselves confer no dividends or votes.

The Trap: Confusing the warrant sweetener with rights-offering anti-dilution, or assuming warrants raise cash at issuance

• existing shareholders are protected against dilution of their ownership percentage: Rights vs. warrants confusion: anti-dilution protection is the purpose of preemptive RIGHTS offered to existing shareholders, not of warrants attached to a bond deal.
• the company receives immediate additional capital when investors exercise the warrants at the offering: Timing misconception: warrants are issued with an exercise price ABOVE the current market, so exercise — and any resulting capital — happens only years later, if the stock rises.
• the debenture holders become entitled to dividends and voting rights: Warrant-feature error: warrants carry no dividends and no voting rights until exercised into common shares.

Verified against: rights vs. warrants confusion pair)

Answer: warrant

Work through the identifying features: the instrument runs for six years (long-term), its $45 exercise price sits well above the $30 market (out of the money at issuance), and it was issued by the company itself. That combination defines a warrant. A preemptive right fails on every count — rights live for only weeks and carry a subscription price below the market so shareholders will actually use them. A listed call option fails on the issuer: standardized options are created and guaranteed by the OCC, not the corporation, and even the longest listed options run far shorter than six years. A convertible security involves surrendering an existing bond or preferred share in exchange for common, not paying cash to subscribe. A useful contrast to remember: rights are short and priced below market; warrants are long and priced above market.

The Trap: Labeling any stock-purchase privilege a 'right' without checking term length and exercise price vs. market

• preemptive right: Rights vs. warrants confusion: rights are SHORT-term (weeks) with a subscription price BELOW the current market — the opposite profile on both counts.
• convertible security: Conversion vs. subscription confusion: a convertible is an existing bond or preferred EXCHANGED for common; this certificate is a stand-alone privilege to BUY new shares for cash.
• exchange-listed call option: Issuer confusion: standardized listed options are issued and guaranteed by the Options Clearing Corporation (OCC), not by the company, and have much shorter terms.

Verified against: rights vs. warrants — most-flagged equity mix-up)

Answer: She may sell the rights in the market, since they trade separately and have value of their own

Preemptive rights are themselves securities: they are issued one per outstanding share, they trade in the market during the offering period (typically a matter of weeks), and they have value because the subscription price is set below the stock's current market price. A shareholder who does not want more shares can simply sell her rights and pocket that value. Rights do expire worthless if ignored — but 'non-transferable' is false. Skipping the offering does not touch the voting rights of shares she already owns; it only means her percentage ownership will shrink slightly as new shares are issued. And the standby underwriter's commitment runs to the issuer — buying whatever shares go unsubscribed — not to rights holders.

The Trap: Believing unexercised rights are worthless/non-transferable or that the issuer must buy them back

• Nothing — unexercised rights are non-transferable and simply expire: Non-transferability misconception: while rights DO expire if ignored, they are tradable, so letting them lapse is a choice, not the only outcome.
• She must exercise the rights to preserve the voting power of the shares she already owns: Rights-vs-voting confusion: declining a rights offering dilutes her ownership PERCENTAGE going forward but takes nothing away from the votes attached to her existing shares.
• She may return the rights to Pinehurst, which is required to buy them back at the subscription price: Standby-underwriter confusion: a standby underwriter agrees to purchase unsubscribed SHARES from the issuer; no one is obligated to repurchase rights from holders.

Verified against: standby underwriter role)

Answer: To act as a sweetener that lets Ardenne offer the debentures with a lower coupon

Warrants are long-term (multi-year) options to purchase the issuer's common stock, usually at an exercise price above the market price at issuance. Companies attach them to debenture or preferred offerings as a "sweetener": the equity upside makes the package more attractive, letting the issuer pay a lower coupon than it otherwise could. Warrant holders are not shareholders — they have no voting rights (option A) and receive no dividends (option D) unless they exercise. Option B describes preemptive rights, which go to existing shareholders in a rights offering to prevent dilution — the classic rights-vs-warrants trap: rights are short-term with a subscription price below market; warrants are long-term with an exercise price above market at issuance.

The Trap: Confusing warrants (long-term sweetener for bond buyers) with preemptive rights (short-term anti-dilution device for existing shareholders)

• To provide bondholders with current dividend income in addition to interest: Misconception that warrants generate income. Warrants pay no dividends; they have value only from the option to buy stock later.
• To give bondholders voting power in corporate matters while the debentures are outstanding: Misconception that warrants confer shareholder rights. Warrant holders have no voting rights and no dividends unless and until they exercise into common stock.
• To allow existing shareholders to maintain their proportionate ownership in the company: This is the classic rights-vs-warrants mix-up, one of the most commonly tested equity confusions on the exam. Anti-dilution protection describes preemptive RIGHTS issued to existing shareholders, not warrants attached to a bond offering.

Verified against: Standard corporate-finance mechanics of warrants used as debt-offering sweeteners; general securities product knowledge, no single governing rule

Answer: Sell the rights in the secondary market, since they trade separately and carry value

Preemptive rights let existing shareholders buy new shares — typically at a subscription price below the current market ($32 versus $38 here) — to protect against dilution. A shareholder who does not want to subscribe has a valuable alternative: rights are tradable securities, so selling them in the market converts the discount into cash. Option B is the costly non-answer: rights that expire unexercised are simply lost value, and because other investors subscribe at the discount, her percentage ownership is diluted anyway. Option C confuses rights with warrants — rights typically live only about 30 to 60 days, while warrants run for years. Option D repeats the false idea that rights are locked to the original holder; in fact a standby underwriter often stands ready to purchase whatever shares go unsubscribed. Knowing the sell-the-rights option is the practical takeaway examiners reward.

The Trap: Believing rights are non-transferable or long-lived, or that letting them expire is costless

• Return the rights to Delaford, because preemptive rights are non-transferable: Misconception that rights cannot be sold. Rights are transferable securities with their own secondary market during the offering period.
• Hold the rights for several years in case the stock climbs further: The rights-vs-warrants term mix-up. Rights are SHORT-term instruments, typically alive for roughly 30 to 60 days; it is warrants that run for years.
• Allow the rights to lapse, since unexercised rights have no economic cost to her: Ignores the give-up. Letting valuable rights expire forfeits money she could have collected by selling, while the new below-market shares issued to others dilute her proportionate stake.

Verified against: Standard mechanics of shareholder preemptive rights offerings (rights are separately tradable); general securities product knowledge, no single governing rule

Answer: Have no intrinsic value now, but typically retain time value and can be sold in the market given their long remaining life

Warrants are typically issued with an exercise price above the current market — being out of the money at issuance is normal, not a defect. With the stock at $39 and the exercise price at $45, these warrants have zero intrinsic value, but four years of remaining life generally gives them meaningful time value: the market pays for the chance the stock rises above $45 before expiration. Because warrants are detachable, tradable securities, the customer can sell them rather than exercise. Option A equates "out of the money" with "worthless," ignoring time value. Option B would have the customer pay $45 for a $39 stock — exercising an out-of-the-money warrant is economically irrational. Option C invents income: warrant holders receive no dividends and no voting rights unless they exercise. Warrants are leveraged, speculative instruments — value can swing sharply and can expire at zero — which is exactly why they suit speculation rather than income objectives.

The Trap: Equating out-of-the-money with worthless — ignoring time value and tradability of long-dated warrants

• Should be exercised immediately, before they lose any remaining value: Misunderstands exercise mechanics — exercising now would mean paying $45 per share for stock available in the market at $39, a guaranteed loss versus simply buying the stock.
• Will pay dividends while held, which supports their value: Misconception that warrants carry shareholder benefits. Warrant holders receive no dividends and no votes unless and until they exercise into common stock.
• Are worthless, because the stock is trading below the exercise price: The intrinsic-value-only misconception. An out-of-the-money warrant has no intrinsic value, but with four years of life remaining it typically still commands a market price for its time value.

Verified against: Standard warrant valuation mechanics (intrinsic value vs. time value); general securities product knowledge, no single governing rule

Answer: Act as a sweetener that lets the issuer market the debt with a lower coupon than it would otherwise have to pay

Warrants attached to a bond or preferred offering are called a "sweetener": the long-dated option on the issuer's common stock gives buyers extra upside, so the issuer can offer a lower coupon and still sell the deal. At issuance a warrant's exercise price is set above the stock's market price (out of the money), and warrants typically run for years — many are detachable and trade separately. Choice A describes preemptive rights, which protect existing shareholders from dilution — the single most common rights/warrants mix-up. Choice B reverses the pricing: rights are priced below market; warrants above. Choice D is wrong because warrant holders are not shareholders — no dividends, no votes — until exercise. These are standard equity-securities concepts under the Securities Act of 1933 framework for corporate offerings.

The Trap: Confusing the warrant's sweetener purpose with the anti-dilution purpose of preemptive rights

• Give existing shareholders a way to maintain their proportionate ownership when new shares are issued: Rights-vs-warrants confusion: anti-dilution protection for existing shareholders is the purpose of preemptive RIGHTS, not warrants.
• Provide bondholders with immediate intrinsic value, since warrants are exercisable below the stock's current market price at issuance: Attribute swap: warrants are issued with an exercise price ABOVE the current market (out of the money); it is rights that are priced below market.
• Guarantee bondholders a dividend payment until the warrants are exercised: Misconception that warrants carry shareholder benefits: warrant holders receive no dividends and no voting rights until they exercise and become shareholders.

Verified against: SIE Content Outline 2.1 Equity Securities

Answer: The right lets her buy stock below the market price and expires within weeks, while the warrant's exercise price was set above the market and it may not expire for years

This is the single most-tested equity contrast. Preemptive rights go to existing shareholders (one right per outstanding share), carry a subscription price BELOW the current market, and expire quickly — typically within 30 to 60 days. Warrants arrive as sweeteners on bond or preferred offerings, carry an exercise price ABOVE the market at issuance (out of the money), and can run for years. A memorable framing: rights are short and cheap; warrants are long and out of the money. Choice A wrongly prices the right above market; choice C swaps the terms; choice D reflects the misconception that these derivative-like instruments confer shareholder benefits — neither pays dividends nor votes before exercise. Nail the two-by-two grid (price vs. market, time to expiration) and every variant of this question falls quickly.

The Trap: Swapping the pricing and term attributes of rights (below market, short-term) and warrants (above market, long-term)

• The warrant will expire before the right, because warrants are the shorter-term instrument: Term-length swap: warrants are the LONG-term instrument (often years); rights are the short-term one (weeks).
• Both the right's subscription price and the warrant's exercise price were set above $40 when issued: Attribute swap: rights are issued with a subscription price BELOW the current market so shareholders have an incentive to subscribe; only the warrant is priced above market.
• Both instruments pay her the common dividend until she exercises them: Shareholder-privileges misconception: neither rights nor warrants pay dividends or carry votes — those benefits begin only after exercise, when the holder actually owns the stock.

Verified against: Warrants), §1.2/§1.3 (rights-vs-warrants contrast); SIE Content Outline 2.1

Answer: Purchase all unsubscribed shares for its own account on a firm-commitment basis

In a rights offering, the issuer cannot know in advance how many shareholders will subscribe. A standby underwriter solves that uncertainty: it agrees, on a firm-commitment basis, to purchase any shares left unsubscribed when the rights expire — so the issuer is guaranteed the full amount of new capital. Choice B describes best-efforts underwriting, where the bank is only an agent and takes no inventory risk; that is the classic confusion this question targets. Choice D describes an all-or-none contingency offering, which is cancelled if not fully sold — the opposite of what a standby commitment accomplishes. Choice A imagines the issuer absorbing the shortfall, which defeats the purpose of hiring the standby underwriter. Tie the word "standby" to its function: the bank stands by to take whatever the shareholders leave behind.

The Trap: Confusing a standby (firm-commitment) underwriter with a best-efforts or all-or-none arrangement

• Return the unsubscribed shares to the issuer, which simply raises less capital: Misconception that a standby arrangement leaves the issuer bearing the shortfall — the whole point of standby underwriting is that the issuer's capital raise is assured.
• Cancel the offering and return all subscription payments, as in an all-or-none underwriting: All-or-none confusion: AON deals are cancelled if not fully sold, but a standby commitment exists precisely so the rights offering does NOT fail when subscriptions fall short.
• Use its best efforts to find buyers for the leftover shares but accept no financial responsibility for what remains unsold: Standby-vs-best-efforts confusion: in a best-efforts deal the underwriter acts as agent with no purchase commitment; a standby underwriter commits its own capital.

Verified against: SIE Content Outline 2.1 / underwriting types

Answer: She may sell the rights in the market before they expire, because they trade separately and have value

In a rights offering, existing shareholders receive short-term, tradable rights to buy new shares below the current market price — here, $32 versus a $38 market. A shareholder who does not want more stock has a valuable third choice beyond exercising or doing nothing: sell the rights before they expire. Letting them lapse simply forfeits value. Option A reverses the rights/warrants pricing pattern — rights are issued with a subscription price BELOW market (that discount is the value), while warrants are issued with an exercise price ABOVE market. Option C also confuses rights with warrants: rights typically expire within about 30 to 60 days, while warrants can run for years. Option D is wrong because rights are transferable securities that trade in the market. Preemptive rights exist to let shareholders avoid dilution of their proportionate ownership, a protection rooted in the corporate charter under state law.

The Trap: Rights are worthless unless exercised / rights-vs-warrants duration and moneyness reversal

• She can safely hold the rights, because they typically remain exercisable for several years: Misconception: rights-vs-warrants duration confusion — rights are short-term (typically expiring in roughly 30–60 days); it is warrants that run for years.
• She should let the rights expire, because a subscription price below the current market price means they have no value: Misconception: inverting the moneyness logic — a subscription price BELOW market is exactly what gives rights value (buy at $32, stock worth $38); it is warrants whose exercise price is set above market at issuance.
• The rights cannot be sold, because they are issued only to existing shareholders: Misconception: treating rights as non-transferable — although issued to existing shareholders, rights trade in the secondary market, which is precisely how a shareholder who declines to subscribe captures their value.

Verified against: rights vs. warrants confusion pair); taxonomy 2.1.1